Tranexamic acid and bevacizumab in hereditary hemorrhagic telangiectasia patients presenting with epistaxis

Cutis. 2013 Apr;91(4):173-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antifibrinolytic Agents / therapeutic use*
  • Epistaxis / drug therapy*
  • Female
  • Humans
  • Telangiectasia, Hereditary Hemorrhagic / drug therapy*
  • Tranexamic Acid / therapeutic use*

Substances

  • Antifibrinolytic Agents
  • Tranexamic Acid